Biotechnology

FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture

One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1) EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2) EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2) THOUSAND OAKS, […]

Global Tech Giant looks to Medical Alley for The Future of Healthcare

Global technology giant Cisco Systems visited Medical Alley with a dozen key Australian customers to better ascertain the future direction of healthcare. In what has become an annual tour of the U.S., Cisco’s Australian division visits technology and health innovation sites around the U.S. including Minneapolis, San Francisco, and Boston. The group sought perspectives on […]

Medical Alley Powering the Evolution of Healthcare with More Than $2.8 Billion Invested and $2 Billion in Exits

Medical Alley companies have raised more than $2.8 billion over the past 5 years, furthering the region’s reputation as the global epicenter of health innovation and care. For the second year in a row, Medical Alley’s diverse healthcare ecosystem raised more than $700 million across the sectors of medical device, digital health, biotechnology and new […]

Record Q1 Investment Showcases Shift to Consumer-Focused Health

Q1 record with 26 Medical Alley companies raising $112 million in capital and a pair of companies acquired for $1.6 billion. Investors are backing Medical Alley companies leading a shift to a consumer- and patient-centric healthcare system. Building on a record 2017, Medical Alley’s leadership continued in a record Q1 that saw $112 million raised […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER